Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J M Lewis

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|April 27, 2017
In depth comparative phenotyping of blood innate myeloid leukocytes from healthy humans and macaques using mass cytometryJamila Elhmouzi-Younes, Jean-Louis Palgen, Nicolas Tchitchek, et al.
Vaccine|November 14, 2020
Safety biomarkers for development of vaccines and biologics: Report from the safety biomarkers symposium held on November 28-29, 2017, Marcy l'Etoile, FranceMichel Doubovetzky, Yasemin Ataman-Önal, Benjamin Chousterman, et al.
Infection and Immunity|January 24, 2003
Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin aKingston H G Mills, Catherine Cosgrove, Edel A McNeela, et al.
Frontiers in Immunology|December 6, 2017
Molecular Signatures of Immunity and Immunogenicity in Infection and VaccinationMariëlle C Haks, Barbara Bottazzi, Valentina Cecchinato, et al.
Frontiers in Immunology|February 22, 2021
Systematic Evaluation of Kinetics and Distribution of Muscle and Lymph Node Activation Measured by <sup>18</sup>F-FDG- and <sup>11</sup>C-PBR28-PET/CT Imaging, and Whole Blood and Muscle Transcriptomics After Immunization of Healthy Humans With Adjuvanted and Unadjuvanted VaccinesZarni Win, January Weiner Rd, Allan Listanco, et al.
The Lancet. HIV|March 20, 2019
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trialFrances H Priddy, David J M Lewis, Huub C Gelderblom, et al.
Vaccine|January 22, 2008
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteersChristine Sadorge, Anna Ndiaye, Nathalie Beveridge, et al.
Ebiomedicine|July 25, 2017
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in EuropeOdile Launay, David J M Lewis, Alessandra Anemona, et al.
Journal of Virology|April 3, 2024
Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccinationNathalie Mantel, Fabienne Piras-Douce, Emilie Chautard, et al.
The Lancet. Infectious Diseases|August 2, 2015
Ebola: missed opportunities for Europe-Africa researchGiuseppe Ippolito, Simone Lanini, Philippe Brouqui, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|April 27, 2017
In depth comparative phenotyping of blood innate myeloid leukocytes from healthy humans and macaques using mass cytometryJamila Elhmouzi-Younes, Jean-Louis Palgen, Nicolas Tchitchek, et al.
Vaccine|November 14, 2020
Safety biomarkers for development of vaccines and biologics: Report from the safety biomarkers symposium held on November 28-29, 2017, Marcy l'Etoile, FranceMichel Doubovetzky, Yasemin Ataman-Önal, Benjamin Chousterman, et al.
Infection and Immunity|January 24, 2003
Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin aKingston H G Mills, Catherine Cosgrove, Edel A McNeela, et al.
Frontiers in Immunology|December 6, 2017
Molecular Signatures of Immunity and Immunogenicity in Infection and VaccinationMariëlle C Haks, Barbara Bottazzi, Valentina Cecchinato, et al.
Frontiers in Immunology|February 22, 2021
Systematic Evaluation of Kinetics and Distribution of Muscle and Lymph Node Activation Measured by <sup>18</sup>F-FDG- and <sup>11</sup>C-PBR28-PET/CT Imaging, and Whole Blood and Muscle Transcriptomics After Immunization of Healthy Humans With Adjuvanted and Unadjuvanted VaccinesZarni Win, January Weiner Rd, Allan Listanco, et al.
The Lancet. HIV|March 20, 2019
Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trialFrances H Priddy, David J M Lewis, Huub C Gelderblom, et al.
Vaccine|January 22, 2008
Phase 1 clinical trial of live attenuated Shigella dysenteriae type-1 DeltaicsA Deltaent Deltafep DeltastxA:HgR oral vaccine SC599 in healthy human adult volunteersChristine Sadorge, Anna Ndiaye, Nathalie Beveridge, et al.
Ebiomedicine|July 25, 2017
Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in EuropeOdile Launay, David J M Lewis, Alessandra Anemona, et al.
Journal of Virology|April 3, 2024
Cynomolgus macaques as a translational model of human immune responses to yellow fever 17D vaccinationNathalie Mantel, Fabienne Piras-Douce, Emilie Chautard, et al.
The Lancet. Infectious Diseases|August 2, 2015
Ebola: missed opportunities for Europe-Africa researchGiuseppe Ippolito, Simone Lanini, Philippe Brouqui, et al.
Pageof 5